Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...

Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a mapping and dual-energy catheter ablation system for treatment of persistent AF. The system ...

日本メドトロニック株式会社（本社：東京都港区）は、「Affera(TM) Mapping and Ablation システム」および「Sphere-9(TM) カテーテル」（以下、Affera Mapping and Ablation システム）が心臓の電気生理学的マッピング、及び薬剤抵抗性の再発性症候性発作性心房細動、薬剤 ...

Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system featuring the Sphere-9 Catheter. This innovative, all-in-one system combines ...

―心房細動治療の新たな選択肢として、より効率的なアブレーション治療を可能に― 日本メドトロニック株式会社（本社：東京都港区）は、「Affera(TM) Mapping and Ablation システム」および「Sphere-9(TM) カテーテル」（以下、Affera Mapping and Ablation システム）が ...

Enrollment completed ahead of schedule in the global IDE for Abbott's Volt™ PFA System Global FOCALFLEX trial now underway for Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ Advisor™ HD ...

Highly anticipated by electrophysiologists for its innovation and demonstrated safety and efficacy as well as improved workflow and short learning curve Now with two pulsed field ablation (PFA) ...

―心房細動治療の新たな選択肢として、より効率的なアブレーション治療を可能に―日本メドトロニック株式会社（本社：東京都港区）は、「Affera（TM）Mapping and Ablation システム」および「Sphere－9（TM ...

Using Rhythm AI Ltd.'s stochastic trajectory analysis of ranked signals (STAR) mapping system with pulmonary vein isolation terminated and eliminated recurrence of persistent atrial fibrillation (AF) ...

Please provide your email address to receive an email when new articles are posted on . Acutus Medical announced that its suite of new algorithms for the mapping and ablation of complex atrial ...